Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stuart J. Swiedler is active.

Publication


Featured researches published by Stuart J. Swiedler.


Analytical Biochemistry | 1992

A cell-based assay for evaluating the interaction of heparin-like molecules and basic fibroblast growth factor

Masayuki Ishihara; David J. Tyrrell; Michael C. Kiefer; Philip J. Barr; Stuart J. Swiedler

A simple panning procedure that allows for the evaluation of interactions between various heparin-like molecules and basic FGF has been developed. This assay measures the ability of compounds to inhibit the interaction of transfected human lymphoblastoid cells, UC 729-6 (UC cells), expressing hamster syndecan and basic FGF-coated plastic plates. The transfected cells bind rapidly to basic FGF-coated plates while the control cells do not bind well. Binding of the transfected cells to basic FGF was inhibited by heparin and heparin sulfate (HS), but not by chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. There was little inhibition of binding by chemically modified heparin such as completely desulfated, N-acetylated heparin, completely desulfated, N-sulfated heparin, and N-desulfated, N-acetylated heparin. These results suggested that both the N-sulfate and O-sulfate groups of heparin are required for binding to basic FGF. In addition, inhibition by oligosaccharides derived from depolymerized heparin increased with fragment size; partial inhibition was observed with oligosaccharides as small as hexamers. The biochemical basis for the binding of transfected cells to basic FGF was established by showing a significant increase of 35SO4 incorporation into HS. In particular, the level of 35SO4-HS in the trypsin-releasable (cell surface) pool increased fivefold. This increase was accounted for by demonstration of the presence of HS on immunoprecipitated syndecan from the transfected cells.


Annals of the New York Academy of Sciences | 1991

The Molecular Biology of Heparan Sulfate Fibroblast Growth Factor Receptorsa

Michael C. Kiefer; Masayuki Ishihara; Stuart J. Swiedler; Kevin Crawford; James C. Stephans; Philip J. Barr

Two distinct classes of cell surface FGF-binding proteins have been identified. These receptors differ in both mode of interaction and in affinity for the FGFs. cDNAs that encode the low-affinity receptor were isolated from a hamster kidney cell line cDNA library by expression cloning. Transfected cells that contained these heparan sulfate proteoglycan FGF receptor cDNAs were enriched for by panning on basic FGF-coated plates. The analogous human cDNA was isolated from a hepatoma cell line cDNA library. The homology of our hamster cDNAs to the previously described murine integral membrane proteoglycan syndecan, together with an exact amino acid sequence match of our human-cDNA-encoded product to human syndecan, clearly indicates the identity of these independently isolated proteoglycans. Further confirmation that the expressed molecule serves as a proteoglycan core protein was achieved by immunoprecipitation of 35SO4-labeled material from solubilized transfected cells. Nitrous acid treatment and chondroitinase digestion revealed that 77% of the label was associated with heparan sulfate chains and 22% with chondroitin sulfate chains. These heparan sulfate chains contributed to the fivefold increase in the total heparan sulfate found to be present on the surface of the transfected cells compared with cells transfected with a vector lacking the cDNA insert.


Analytical Biochemistry | 1992

Selection of COS cell mutants defective in the biosynthesis of heparan sulfate proteoglycan

Masayuki Ishihara; Michael C. Kiefer; Philip J. Barr; Yuchuan Guo; Stuart J. Swiedler

A simple procedure using human basic fibroblast growth factor (FGF) was utilized for the selection of COS cell mutants with defects in the biosynthesis or expression of heparan sulfate proteoglycan (HSPG). Our approach was based on the strong binding affinity exhibited by COS cells to human basic FGF that had been adsorbed to plastic dishes. Cell binding to basic FGF could be inhibited by heparin and heparan sulfate (HS), but not by chondroitin sulfate, dermatan sulfate, keratan sulfate, or hyaluronic acid, suggesting that the cell binding involved an interaction between basic FGF and cell surface heparin-like molecules. COS cells were treated with ethyl methanesulfonate and four stable mutants were subsequently isolated that did not bind strongly to basic FGF adsorbed to plastic. These mutants cell lines (CM-2, CM-8, CM-9, and CM-15) exhibited significantly reduced 35SO4 incorporation into HS (40-70% depending on the cellular pool analyzed). In one of these cell lines, CM-15, the incorporation of [6-3H]glucosamine into HS was unaltered, suggesting that the extent of oligosaccharide polymerization was equivalent to that observed for the wild-type cells. Structural analysis revealed that N-sulfated glucosamine residues were present much less frequently in HS derived from these cells as compared with that derived from wild-type cells. Furthermore, CM-15 was found to be three-fold deficient in HS N-sulfotransferase activity, but contained wild-type levels of HS O-sulfotransferase activities.(ABSTRACT TRUNCATED AT 250 WORDS)


Proceedings of the National Academy of Sciences of the United States of America | 1991

Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1.

Michael Tiemeyer; Stuart J. Swiedler; Masayuki Ishihara; Margaret Moreland; Hans Schweingruber; Pam Hirtzer; Brian K. Brandley


Archive | 1991

Method of determining a site of inflammation utilizing elam-1 ligands

Brian K. Brandley; Michael Tiemeyer; Stuart J. Swiedler; Margaret Moreland; Hans Schweingruber


Journal of Biological Chemistry | 1993

Regulation of biosynthesis of the basic fibroblast growth factor binding domains of heparan sulfate by heparan sulfate-N-deacetylase/N-sulfotransferase expression

Masayuki Ishihara; Yuchuan Guo; Zheng Wei; Zicheng Yang; Stuart J. Swiedler; A. Orellana; C. B. Hirschberg


Archive | 1991

New carbohydrate-based anti-inflammatory agents

Brian K. Brandley; Michael Tiemeyer; Stuart J. Swiedler; Margaret Moreland; Hans Schweingruber


Archive | 1992

Methods of treating inflammation using selection binding compounds

Brian K. Brandley; Michael Tiemeyer; Stuart J. Swiedler; Margaret Moreland; Hans Schweingruber; Narasinga Rao


Archive | 1993

Glycosaminoglycan specific sulfotransferases

Carlos B. Hirschberg; Ariel Orellana; Yasuhiro Hashimoto; Stuart J. Swiedler; Zheng Wei; Masayuki Ishihara


Glycobiology | 1993

Selective impairment of the synthesis of basic fibroblast growth factor binding domains of heparan sulphate in a COS cell mutant defective in N-sulphotransferase

Masayuki Ishihara; Yuchuan Guo; Stuart J. Swiedler

Collaboration


Dive into the Stuart J. Swiedler's collaboration.

Top Co-Authors

Avatar

Masayuki Ishihara

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masayuki Ishihara

National Defense Medical College

View shared research outputs
Top Co-Authors

Avatar

Ariel Orellana

University of Massachusetts Amherst

View shared research outputs
Top Co-Authors

Avatar

Carlos B. Hirschberg

University of Massachusetts Amherst

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuhiro Hashimoto

University of Massachusetts Amherst

View shared research outputs
Researchain Logo
Decentralizing Knowledge